Why Plants Are the Future of Biologics: The Science Behind Recombinant Protein Drugs

Reading Time: 5 minutesBiologics—the creation of recombinant protein drugs—have been revolutionary in treating complex diseases. They provide targeted therapies for conditions including cancer and autoimmune disorders. Over the past 50 years, scientists have produced these complex proteins in mammalian cells, bacterial cultures, yeast, and plants.
Throughout the 2010s and into the 2020s,
Top Trends in Biopharmaceutical Outsourcing

Reading Time: 6 minutesBiopharmaceutical outsourcing has changed a lot in the last few years. Teams are not only looking for extra hands or lab space; they want partners who help them make smarter decisions, move faster, and document work so regulators can follow the story without friction.
How to Choose the Right CDMO Partner for Protein Production

Reading Time: 6 minutesChoosing your CDMO partner for protein production is one of the most important decisions a biopharmaceutical company will make. Whether you’re developing a new therapeutic protein, monoclonal antibody, or vaccine candidate, selecting the right CDMO services can accelerate timelines, ensure regulatory compliance, and reduce manufacturing costs.
